Institute for Medical Physics and Biophysics, Medical Faculty, Leipzig University, Leipzig, Germany.
Institute for Anatomy, Medical Faculty, Leipzig University, Leipzig, Germany.
J Alzheimers Dis. 2018;61(3):963-984. doi: 10.3233/JAD-170711.
While the etiology of Alzheimer's disease (AD) is still unknown, an increased formation of amyloid-β (Aβ) peptide and oxidative processes are major pathological mechanism of the disease. The interaction of Aβ with free heme leads to the formation of peroxidase-active Aβ-heme complexes. However, enzyme-kinetic data and systematic mutational studies are still missing. These aspects were addressed in this study to evaluate the role of Aβ-heme complexes in AD. The enzyme-kinetic measurements showed peroxidase-specific pH- and H2O2-dependencies. In addition, the enzymatic activity of Aβ-heme complexes constantly increased at higher peptide excess. Moreover, the role of the Aβ sequence for the named enzymatic activity was tested, depicting human-specific R5, Y10, and H13 as essential amino acids. Also by studying Y10 as an endogenous peroxidase substrate for Aβ-heme complexes, ratio-specific effects were observed, showing an optimal dityrosine formation at an about 40-fold peptide excess. As dityrosine formation promotes Aβ fibrillation while free heme disturbs protein aggregation, we also investigated the effect of Aβ-heme complex-derived peroxidase activity on the formation of Aβ fibrils. The fluorescence measurements showed a different fibrillation behavior at strong peroxidase activity, leading also to altered fibril morphologies. The latter was detected by electron microscopy. As illustrated by selected in vivo measurements on a mouse model of AD, the disease is also characterized by Aβ-derived microvessel destructions and hemolytic processes. Thus, thrombo-hemorrhagic events are discussed as a source for free heme in brain tissue. In summary, we suggest the formation and enzymatic activity of Aβ-heme complexes as pathological key features of AD.
虽然阿尔茨海默病(AD)的病因仍不清楚,但淀粉样β(Aβ)肽的形成增加和氧化过程是该疾病的主要病理机制。Aβ与游离血红素的相互作用导致具有过氧化物酶活性的 Aβ-血红素复合物的形成。然而,酶动力学数据和系统的突变研究仍然缺失。本研究旨在评估 Aβ-血红素复合物在 AD 中的作用,解决了这些方面的问题。酶动力学测量显示过氧化物酶特异性 pH 和 H2O2 依赖性。此外,在肽过量较高时,酶活性不断增加。此外,还测试了 Aβ 序列在该命名酶活性中的作用,描绘了人类特异性的 R5、Y10 和 H13 作为必需氨基酸。通过研究 Y10 作为 Aβ-血红素复合物的内源性过氧化物酶底物,还观察到了比值特异性效应,显示在肽过量约 40 倍时形成最佳的二酪氨酸。由于二酪氨酸的形成促进 Aβ 纤维化,而游离血红素扰乱蛋白质聚集,我们还研究了 Aβ-血红素复合物衍生的过氧化物酶活性对 Aβ 纤维形成的影响。荧光测量显示在强过氧化物酶活性下具有不同的纤维化行为,导致纤维形态也发生改变。后者通过电子显微镜检测到。如 AD 小鼠模型的选定体内测量所示,该疾病还以 Aβ 衍生的微血管破坏和溶血性过程为特征。因此,血栓 - 出血事件被认为是脑组织中游离血红素的来源。总之,我们提出 Aβ-血红素复合物的形成和酶活性作为 AD 的病理关键特征。